Marjon Borgert

184 Chapter 8 ● ● ●● ● ● ●● ●● ● ● ● ● ● ●● ● ● ● ● ● ● ● ●● ● ●● ● ● ●●●● ● ● ● ● ● ● ● ● ●● ● ● ● ● ●● ●● ● ● ● ● ● ●● ● ● ● ● ●● ●● ● ●● ● ●● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●● ●● ● ●● ● ●● ● ● ● ●● ●● ●● ●● ●● ●● ● ● ● ● ● ● ● ●● ● ● ● ●● ● ● ● ● ●● ● ● ●● ● ● ● ● ●● ●● ● ● ● ● ● ● ● ● ● ● ● ●● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●● ● ● ● ● ● ●● ● ●● ● ● ● ● ●● ● ●● ● ● ● ● ● ● ● ● ● ● ● ● ● ●● ● ● ● ●● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●● ●● ● ● ● ●● ● ● ● ● ● ● ● ● ● ● ● ● ●● ● ● ● ● ● ● ● ● ● ●● ●● ● ● ● ● ● ●● ● ● ●● ● ●● ● ● ●● ● ● ● ●● ● ● ●● ●●● ● ● ● ● ● ● ● ● ● ●● ● ● ● ● ● ● ● ●● ● ● ● ● ● ● ●● ● ● ● ● ●● ● ● ● ● ●● ● ● ● ● ● ●● ● ● ●● ● ●● ● ● ●●● ● ●● ● ● ●● ● ● ● ● ● ● ● ● ● ● ● ● ●● ● ●● ●● ● ● ● ● ●●● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●●● ●● ●● ● ● ● ● ● ●● ● ●● ● ● ●● ● ● ●● ●● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●● ● ● ● ● ● ●● ● ●● ●● ●●● ● ● ● ● ● ● ● ● ● ● ● ● ● ●●●● ●● ● ● ● ● ● ● ● ●● ● ● ● ● ●● ● ● ●● ● ● ● ● ● ● ● ●● ● ● ● ●● ●● ● ●● ●● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●● ●● ● ● ●● ● ●● ●● ● ●● ●● ●● ● ● ●● ●● ●● ● ● ● ●● ● ●● ● ● ●● ● ● ● ●● ● ● ● ● ● ● ● ● ● ●●● ● ● ● ● ●● ● ● ● ● ● ● ● ● ● ●● ●● ● ● ● ● ● ● ● ● ● ● ● ● ●● ● ● ● ● ●● ● ● ● ● ● ● ● ● ● ● ●● ● ●●● ● ● ● ●● ● ● ● ● ● ●● ● ● ● ●● ●● ●● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●● ● ●● ● ● ● ● ● ● ● ● ● ● ● ● ● ● ●● ● ●● ● ● ● ● ● ●● ● ● ● ●● ● ● Baseline Phase 1 Phase 2 Ȅ ࠄ ߾ Ȅ ࠁ ߾ ߾ ࠁ ߾ ࠄ ߾ ߾ ߿߾߾ ࠀ ߾߾ ࠁ ߾߾ Da ࠀ ࠼࠷ ࡇ ߾߿ ࠂ Percentage deviation from trigger Hb b ࡇ ࠯ ࡃࡂ࠱ ࠯ ࠺ ࠞ ࠳ࡀ Ȅ ࡂ ransfusie Hb Figure 2. Percentage deviation from patients’ individual pre-set Hb threshold by pre-transfusion Hb level. Light blue dots re ect the transfusions associated with a higher pre-transfusion Hb level than the patients’ individual pre-set Hb threshold